Healthcare Industry News: Solos Endoscopy
News Release - August 21, 2006
Solos Endoscopy Appoints Former US Surgical Sales Manager as Director of Breast Care Product LineBOSTON, MA--(Healthcare Sales & Marketing Network)--Aug 21, 2006 -- Solos Endoscopy, Inc. (Other OTC:SLSE.PK ) is pleased to announce that the Company has appointed Irvin Dee Fletcher as Director of Breast Care Products. Mr. Fletcher will be responsible for expanding distribution channels as the Company launches their preventative medical technology products for the early detection of breast cancer.
Mr. Fletcher has been with Acueity, Inc. since May 2000, where he was responsible for developing sales and distribution channels. While at Acueity, Mr. Fletcher was also a Senior Clinical Specialist and was responsible for working directly with physicians and their staffs. Prior to joining Acueity, Mr. Fletcher was the National Sales Director for M-Pact Corporation's Surgical Products Division, where he implemented the formation of a specialty distribution system which operated throughout the United States and Canada.
Over the duration of Mr. Fletcher's career, he has held Sales Manager positions for several medical device companies such as 3M Corporation, Xomed Surgical, US Surgical, Baxter International, and Merocel Corporation. Mr. Fletcher obtained his BS degree in Business Administration from Dallas Baptist College.
"We are very pleased to be working with a professional like Mr. Fletcher. He brings over 30 years of healthcare sales and sales management experience to our team and will undoubtedly strengthen our management team," stated Robert Segersten, President of Solos Endoscopy, Inc.
Solos Endoscopy, Inc. recently announced that the Company is filing the documents requesting immediate FDA market clearance on the recently acquired MastaScope(TM) and OvaScope(TM) product lines. Solos currently holds FDA market clearance for its line of breast endoscopes and will add the MastaScope(TM) to that line. In addition, Solos has a wide range of additional FDA cleared endoscopes in the market and will also request clearance on the OvaScope(TM).
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: www.solosendoscopy.com.
Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
Source: Solos Endoscopy
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.